LeMaitre Vascular, Inc. (NASDAQ:LMAT) Declares Quarterly Dividend of $0.20

Key Points

• LeMaitre Vascular, Inc. declared a quarterly dividend of $0.20 per share, with a yield of 0.9%, payable on September 4th to stockholders of record on August 21st.
• The company's quarterly earnings report revealed an earnings per share of $0.60, exceeding estimates, with a 15% year-over-year revenue increase.
• LeMaitre Vascular's stock rose by 8.9%, closing at $93.23, with strong trading volume significantly above its average.

LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) declared a quarterly dividend on Wednesday, August 6th, Wall Street Journal reports. Stockholders of record on Thursday, August 21st will be paid a dividend of 0.20 per share by the medical instruments supplier on Thursday, September 4th. This represents a c) annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Thursday, August 21st.

LeMaitre Vascular has a payout ratio of 33.6% indicating that its dividend is sufficiently covered by earnings. Analysts expect LeMaitre Vascular to earn $2.17 per share next year, which means the company should continue to be able to cover its $0.80 annual dividend with an expected future payout ratio of 36.9%.

LeMaitre Vascular Trading Up 8.9%

NASDAQ:LMAT traded up $7.63 on Wednesday, reaching $93.23. 428,610 shares of the stock traded hands, compared to its average volume of 188,543. The firm has a market capitalization of $2.11 billion, a price-to-earnings ratio of 47.09, a price-to-earnings-growth ratio of 2.23 and a beta of 0.79. LeMaitre Vascular has a 1-year low of $71.42 and a 1-year high of $109.58. The company has a current ratio of 16.49, a quick ratio of 13.83 and a debt-to-equity ratio of 0.48. The company's 50 day moving average is $82.64 and its 200-day moving average is $86.68.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The medical instruments supplier reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.57 by $0.03. The business had revenue of $63.15 million for the quarter, compared to analysts' expectations of $62.48 million. LeMaitre Vascular had a return on equity of 13.53% and a net margin of 19.96%. The business's revenue was up 15.0% on a year-over-year basis. During the same period last year, the business earned $0.52 EPS. Equities research analysts anticipate that LeMaitre Vascular will post 1.94 EPS for the current fiscal year.

Insider Buying and Selling at LeMaitre Vascular

In related news, CEO George W. Lemaitre sold 4,399 shares of the company's stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $85.10, for a total transaction of $374,354.90. Following the completion of the sale, the chief executive officer directly owned 1,827,003 shares in the company, valued at $155,477,955.30. This represents a 0.24% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. In the last three months, insiders sold 100,000 shares of company stock valued at $8,556,857. 9.50% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On LeMaitre Vascular

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in LMAT. Opal Wealth Advisors LLC purchased a new stake in LeMaitre Vascular in the first quarter valued at about $26,000. NBC Securities Inc. acquired a new position in shares of LeMaitre Vascular in the first quarter valued at about $36,000. Geneos Wealth Management Inc. increased its holdings in shares of LeMaitre Vascular by 250.3% in the first quarter. Geneos Wealth Management Inc. now owns 557 shares of the medical instruments supplier's stock valued at $47,000 after purchasing an additional 398 shares during the period. BI Asset Management Fondsmaeglerselskab A S acquired a new position in shares of LeMaitre Vascular in the first quarter valued at about $50,000. Finally, US Bancorp DE increased its holdings in shares of LeMaitre Vascular by 36.0% in the first quarter. US Bancorp DE now owns 1,390 shares of the medical instruments supplier's stock valued at $117,000 after purchasing an additional 368 shares during the period. 84.64% of the stock is currently owned by hedge funds and other institutional investors.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.